Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 5950395, 11 pages
https://doi.org/10.1155/2017/5950395
Research Article

Different Modulatory Effects of IL-17, IL-22, and IL-23 on Osteoblast Differentiation

1Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, Shanghai, China
2Department of Rheumatology & Immunology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang, China
3Department of Rheumatology & Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
4Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, China

Correspondence should be addressed to Sheng-Ming Dai; nc.moc.liamdem@msd

Received 21 January 2017; Accepted 4 June 2017; Published 27 July 2017

Academic Editor: Koen Venken

Copyright © 2017 Jing-Ru Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Braun and J. Sieper, “Ankylosing spondylitis,” Lancet, vol. 369, no. 9570, pp. 1379–1390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Braun and X. Baraliakos, “Imaging of axial spondyloarthritis including ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 70, Supplement 1, pp. i97–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), P. R. Burton et al., “Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants,” Nature Genetics, vol. 39, no. 11, pp. 1329–1337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Australo-Anglo-American Spondyloarthritis Consortium (TASC), J. D. Reveille, A. M. Sims et al., “Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci,” Nature Genetics, vol. 42, no. 2, pp. 123–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. I. Davidson, L. Jiang, A. Cortes et al., “Brief report: high-throughput sequencing of IL23R reveals a low-frequency, nonsynonymous single-nucleotide polymorphism that is associated with ankylosing spondylitis in a Han Chinese population,” Arthritis and Rheumatism, vol. 65, no. 7, pp. 1747–1752, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Singh, A. Aggarwal, and R. Misra, “Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy,” The Journal of Rheumatology, vol. 34, no. 11, pp. 2285–2290, 2007. View at Google Scholar
  7. D. Wendling, J. P. Cedoz, E. Racadot, and G. Dumoulin, “Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis,” Joint, Bone, Spine, vol. 74, no. 3, pp. 304-305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Jandus, G. Bioley, J. P. Rivals, J. Dudler, D. Speiser, and P. Romero, “Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2307–2317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Shen, J. C. Goodall, and J. S. Hill Gaston, “Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis,” Arthritis and Rheumatism, vol. 60, no. 6, pp. 1647–1656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Jacques, K. Venken, K. Van Beneden et al., “Invariant natural killer T cells are natural regulators of murine spondylarthritis,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 988–999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Bowness, A. Ridley, J. Shaw et al., “Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis,” Journal of Immunology, vol. 186, no. 4, pp. 2672–2680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Kenna, S. I. Davidson, R. Duan et al., “Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis,” Arthritis and Rheumatism, vol. 64, no. 5, pp. 1420–1429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Sherlock, B. Joyce-Shaikh, S. P. Turner et al., “IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells,” Nature Medicine, vol. 18, no. 7, pp. 1069–1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Wang, Z. Lin, Q. Wei, Y. Jiang, and J. Gu, “Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis,” Rheumatology International, vol. 29, no. 11, pp. 1343–1347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. DeLay, M. J. Turner, E. I. Klenk, J. A. Smith, D. P. Sowders, and R. A. Colbert, “HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats,” Arthritis and Rheumatism, vol. 60, no. 9, pp. 2633–2643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ruutu, G. Thomas, R. Steck et al., “Beta-glucan triggers spondylarthritis and Crohn’s disease-like ileitis in SKG mice,” Arthritis and Rheumatism, vol. 64, no. 7, pp. 2211–2222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Glatigny, I. Fert, M. A. Blaton et al., “Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats,” Arthritis and Rheumatism, vol. 64, no. 1, pp. 110–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Baeten, X. Baraliakos, J. Braun et al., “Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial,” Lancet, vol. 382, no. 9906, pp. 1705–1713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. I. E. Adamopoulos, C. C. Chao, R. Geissler et al., “Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors,” Arthritis Research & Therapy, vol. 12, no. 1, article R29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Sato, A. Suematsu, K. Okamoto et al., “Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction,” The Journal of Experimental Medicine, vol. 203, no. 12, pp. 2673–2682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. I. E. Adamopoulos and E. P. Bowman, “Immune regulation of bone loss by Th17 cells,” Arthritis Research & Therapy, vol. 10, no. 5, p. 225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kotake, N. Udagawa, N. Takahashi et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” The Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345–1352, 1999. View at Publisher · View at Google Scholar
  23. T. Yago, Y. Nanke, M. Kawamoto et al., “IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats,” Arthritis Research & Therapy, vol. 9, no. 5, article R96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Chen, X. Q. Wei, B. Evans, W. Jiang, and D. Aeschlimann, “IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells,” European Journal of Immunology, vol. 38, no. 10, pp. 2845–2854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” The Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Bakker and J. Klein-Nulend, “Osteoblast isolation from murine calvariae and long bones,” Methods in Molecular Medicine, vol. 80, pp. 19–28, 2003. View at Publisher · View at Google Scholar
  27. M. Ishiyama, H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno, “A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet,” Biological & Pharmaceutical Bulletin, vol. 19, no. 11, pp. 1518–1520, 1996. View at Google Scholar
  28. E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel, “Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes,” The Journal of Biological Chemistry, vol. 275, no. 26, pp. 19992–20001, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. T. A. Owen, M. Aronow, V. Shalhoub et al., “Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix,” Journal of Cellular Physiology, vol. 143, no. 3, pp. 420–430, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. P. V. Hauschka, J. B. Lian, D. E. Cole, and C. M. Gundberg, “Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone,” Physiological Reviews, vol. 69, no. 3, pp. 990–1047, 1989. View at Google Scholar
  31. M. Bruderer, R. G. Richards, M. Alini, and M. J. Stoddart, “Role and regulation of RUNX2 in osteogenesis,” European Cells & Materials, vol. 28, pp. 269–286, 2014. View at Google Scholar
  32. D. Toy, D. Kugler, M. Wolfson et al., “Cutting edge: interleukin 17 signals through a heteromeric receptor complex,” Journal of Immunology, vol. 177, no. 1, pp. 36–39, 2006. View at Google Scholar
  33. S. L. Gaffen, “Structure and signalling in the IL-17 receptor family,” Nature Reviews. Immunology, vol. 9, no. 8, pp. 556–567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Dumoutier, J. Louahed, and J. C. Renauld, “Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9,” Journal of Immunology, vol. 164, no. 4, pp. 1814–1819, 2000. View at Google Scholar
  35. L. Dumoutier, E. Van Roost, D. Colau, and J. C. Renauld, “Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 10144–10149, 2000. View at Publisher · View at Google Scholar
  36. B. Oppmann, R. Lesley, B. Blom et al., “Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12,” Immunity, vol. 13, no. 5, pp. 715–725, 2000. View at Google Scholar
  37. L. Limon-Camacho, M. I. Vargas-Rojas, J. Vazquez-Mellado et al., “In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis,” The Journal of Rheumatology, vol. 39, no. 4, pp. 830–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. W. P. Maksymowych, D. Elewaut, and G. Schett, “Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation,” Arthritis and Rheumatism, vol. 64, no. 6, pp. 1713–1719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. D. van der Heijde, R. Landewe, S. Einstein et al., “Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1324–1331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Lories, I. Derese, C. de Bari, and F. P. Luyten, “Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis,” Arthritis and Rheumatism, vol. 56, no. 2, pp. 489–497, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. W. P. Maksymowych, P. Chiowchanwisawakit, T. Clare, S. J. Pedersen, M. Ostergaard, and R. G. Lambert, “Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 93–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Chiowchanwisawakit, R. G. Lambert, B. Conner-Spady, and W. P. Maksymowych, “Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis,” Arthritis and Rheumatism, vol. 63, no. 8, pp. 2215–2225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Bilbe, E. Roberts, M. Birch, and D. B. Evans, “PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines,” Bone, vol. 19, no. 5, pp. 437–445, 1996. View at Google Scholar
  44. D. Wang, K. Christensen, K. Chawla, G. Xiao, P. H. Krebsbach, and R. T. Franceschi, “Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential,” Journal of Bone and Mineral Research, vol. 14, no. 6, pp. 893–903, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Katagiri, A. Yamaguchi, M. Komaki et al., “Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage,” The Journal of Cell Biology, vol. 127, no. 6, Part 1, pp. 1755–1766, 1994. View at Google Scholar
  46. Y. G. Kim, J. W. Park, J. M. Lee et al., “IL-17 inhibits osteoblast differentiation and bone regeneration in rat,” Archives of Oral Biology, vol. 59, no. 9, pp. 897–905, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Kamiya, C. Nakamura, T. Fukawa et al., “Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation,” Journal of Bone and Mineral Metabolism, vol. 25, no. 5, pp. 277–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Huang, H. J. Kim, E. J. Chang et al., “IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling,” Cell Death and Differentiation, vol. 16, no. 10, pp. 1332–1343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Ding, O. Ghali, P. Lencel et al., “TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells,” Life Sciences, vol. 84, no. 15-16, pp. 499–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Zhao, J. Huang, H. Zhang et al., “Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1,” Stem Cells, vol. 29, no. 10, pp. 1601–1610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. H. L. Lee, T. Yi, K. Baek et al., “Tumor necrosis factor-alpha enhances the transcription of Smad ubiquitination regulatory factor 1 in an activating protein-1- and Runx2-dependent manner,” Journal of Cellular Physiology, vol. 228, no. 5, pp. 1076–1086, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. H. H. Cho, K. K. Shin, Y. J. Kim et al., “NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression,” Journal of Cellular Physiology, vol. 223, no. 1, pp. 168–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Hess, A. Ushmorov, J. Fiedler, R. E. Brenner, and T. Wirth, “TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway,” Bone, vol. 45, no. 2, pp. 367–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. G. E. Glass, J. K. Chan, A. Freidin, M. Feldmann, N. J. Horwood, and J. Nanchahal, “TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 4, pp. 1585–1590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Osta, G. Benedetti, and P. Miossec, “Classical and paradoxical effects of TNF-alpha on bone homeostasis,” Frontiers in Immunology, vol. 5, p. 48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Chen, C. Deng, and Y. P. Li, “TGF-beta and BMP signaling in osteoblast differentiation and bone formation,” International Journal of Biological Sciences, vol. 8, no. 2, pp. 272–288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. P. ten Dijke, “Bone morphogenetic protein signal transduction in bone,” Current Medical Research and Opinion, vol. 22, Supplement 1, pp. S7–11, 2006. View at Publisher · View at Google Scholar
  58. V. Rosen, “BMP2 signaling in bone development and repair,” Cytokine & Growth Factor Reviews, vol. 20, no. 5-6, pp. 475–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Yamazaki, H. Fukushima, M. Shin et al., “Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB,” The Journal of Biological Chemistry, vol. 284, no. 51, pp. 35987–35995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. R. L. Huang, Y. Yuan, J. Tu, G. M. Zou, and Q. Li, “Opposing TNF-alpha/IL-1beta- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation,” Cell Death & Disease, vol. 5, article e1187, 2014. View at Publisher · View at Google Scholar · View at Scopus